Inducing cellular immune responses to hepatitis B virus using peptide compositions
US7611713B2 · kind B2 · utility
1Cited by
37References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2003 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Sep 4, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to develop epitope-based vaccines directed towards HBV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HBV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.